This Article Free upon publication Full Text Full Text (PDF) All Versions of this Article: 115/14/1948    most recent CIRCULATIONAHA.107.181946v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCrindle, B. W. Articles by Daniels, S. R. Search for Related Content PubMed PubMed Citation Articles by McCrindle, B. W. Articles by Daniels, S. R. Related Collections Lipids

(Circulation. 2007;115:1948-1967.)
© 2007 American Heart Association, Inc.

AHA Scientific Statement

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents

A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing

Brian W. McCrindle, MD, MPH, Chair; Elaine M. Urbina, MD; Barbara A. Dennison, MD, FAHA; Marc S. Jacobson, MD, FAHA; Julia Steinberger, MD, MS; Albert P. Rocchini, MD, FAHA; Laura L. Hayman, PhD, RN, FAHA; Stephen R. Daniels, MD, PhD, FAHA

Despite compliance with lifestyle recommendations, some children and adolescents with high-risk hyperlipidemia will require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia. The purpose of this statement is to examine new evidence on the association of lipid abnormalities with early atherosclerosis, discuss challenges with previous guidelines, and highlight results of clinical trials with statin therapy in children and adolescents with familial hypercholesterolemia or severe hypercholesterolemia. Recommendations are provided to guide decision-making with regard to patient selection, initiation, monitoring, and maintenance of drug therapy.

Key Words: AHA Scientific Statements • lipids • pediatrics • drugs • hypercholesterolemia

This article has been cited by other articles:

				S. R. Daniels, F. R. Greer, and and the Committee on Nutrition Lipid Screening and Cardiovascular Health in Childhood Pediatrics, July 1, 2008; 122(1): 198 - 208. [Abstract] [Full Text] [PDF]

				K. A. Matyka Type 2 diabetes in childhood: epidemiological and clinical aspects Br. Med. Bull., June 1, 2008; 86(1): 59 - 75. [Abstract] [Full Text] [PDF]

				W. Palinski and C. Napoli Impaired Fetal Growth, Cardiovascular Disease, and the Need to Move on Circulation, January 22, 2008; 117(3): 341 - 343. [Full Text] [PDF]

				J. Steinberger and A. S. Kelly Challenges of Existing Pediatric Dyslipidemia Guidelines: Call for Reappraisal Circulation, January 1, 2008; 117(1): 9 - 10. [Full Text] [PDF]

				C. G. Magnussen, O. T. Raitakari, R. Thomson, M. Juonala, D. A. Patel, J. S.A. Viikari, J. Marniemi, S. R. Srinivasan, G. S. Berenson, T. Dwyer, et al. Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study Circulation, January 1, 2008; 117(1): 32 - 42. [Abstract] [Full Text] [PDF]

				I. Tabas, K. J. Williams, and J. Boren Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications Circulation, October 16, 2007; 116(16): 1832 - 1844. [Abstract] [Full Text] [PDF]

				P. Velasquez-Mieyer, C. P. Neira, R. Nieto, and P. A. Cowan Review: Obesity and cardiometabolic syndrome in children Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 61 - 81. [Abstract] [PDF]

				J. Hendry Statins May Benefit Kids With Recalcitrant Lipids DOC News, October 1, 2007; 4(10): 3 - 8. [Full Text]

				E. A. Stein Statins and Children: Whom Do We Treat and When? Circulation, August 7, 2007; 116(6): 594 - 595. [Full Text] [PDF]

				L. L. Hayman, J. C. Meininger, S. R. Daniels, B. W. McCrindle, L. Helden, J. Ross, B. A. Dennison, J. Steinberger, and C. L. Williams Primary Prevention of Cardiovascular Disease in Nursing Practice: Focus on Children and Youth: A Scientific Statement From the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism Circulation, July 17, 2007; 116(3): 344 - 357. [Full Text] [PDF]

				US Preventive Services Task Force Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement Pediatrics, July 1, 2007; 120(1): e215 - e219. [Full Text] [PDF]

				B. W. McCrindle and for the Writing Group Summary of the American Heart Association's Scientific Statement on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 982 - 985. [Full Text] [PDF]